Melinda Mata

Man's Best Friend: Utilizing Naturally Occurring Tumors in Dogs to Improve Chimeric Antigen Receptor T-cell Therapy for Human Cancers.

S. Gottschalk, Melinda Mata, 2016, Molecular therapy : the journal of the American Society of Gene Therapy.

Inducible Activation of MyD88 and CD40 in CAR T Cells Results in Controllable and Potent Antitumor Activity in Preclinical Solid Tumor Models.

P. Nguyen, S. Gottschalk, D. Spencer, 2017, Cancer discovery.

Toward Immunotherapy With Redirected T Cells in a Large Animal Model: Ex Vivo Activation, Expansion, and Genetic Modification of Canine T Cells

C. Rooney, S. Gottschalk, H. Wilson-Robles, 2014, Journal of immunotherapy.

Abstract LB-147: Administration of HER2-CAR T cells after lymphodepletion safely improves T cell expansion and induces clinical responses in patients with advanced sarcomas

H. Heslop, C. Rooney, K. Sanber, 2019, Clinical Research (Excluding Clinical Trials).

Expansion of HER2-CAR T cells after lymphodepletion and clinical responses in patients with advanced sarcoma.

Hao Liu, H. Heslop, C. Rooney, 2017 .

Antitumor effects of chimeric receptor engineered human T cells directed to tumor stroma.

Hao Liu, K. Pfizenmaier, S. Gottschalk, 2013, Molecular therapy : the journal of the American Society of Gene Therapy.

Adoptive cell therapy for sarcoma.

S. Gottschalk, Melinda Mata, 2015, Immunotherapy.

Engineering for Success: Approaches to Improve Chimeric Antigen Receptor T Cell Therapy for Solid Tumors

S. Gottschalk, Melinda Mata, 2019, Drugs.

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

Charles J. Vaske, Rohan N. Borkar, Brian D. Kelly, 2016, Journal of Immunotherapy for Cancer.

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

Charles J. Vaske, Rohan N. Borkar, David M. Schauder, 2016, Journal for ImmunoTherapy of Cancer.